AvKARE FDA Inspection Record
AvKARE is an FDA-inspected facility (FEI 3007255004) located in Pulaski, TN, US. RegDataLab tracks 4 FDA inspections at this facility.
What FDA found at this site
- Latest inspection
- Nov 2, 2022: Voluntary Action Indicated (VAI)
- Inspections on record
- 4 (1 VAI, 3 NAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Recalls as the recalling firm
- 41, latest Oct 9, 2026
- Import refusals
- 2
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Nov 2, 2022 | Voluntary Action Indicated (VAI) | Procedures not in writing, fully followed (21 CFR 211.22(d)) |
| Aug 23, 2022 | No Action Indicated (NAI) | No citations listed |
| Jun 6, 2017 | No Action Indicated (NAI) | No citations listed |
| Jun 9, 2014 | No Action Indicated (NAI) | No citations listed |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Oct 9, 2026 | Class II | D-0157-2027 | Fludrocortisone Acetate Tablets, USP 0.1mg, Rx Only, 50 Tablets (5 x 10) Unit Dose AVPAK… Failed Impurities/Degradation Specifications |
| Feb 13, 2026 | Class II | D-0341-2026 | Amantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10) unit dose, Rx Only… Failed Dissolution Specifications: This recall has been initiated due to an Out of Specification finding in dissolution. |
| Dec 31, 2025 | Class II | D-0292-2026 | Rosuvastatin Tablets, USP, 10 mg, Rx Only, 50 Tablets (5 x 10) Unit Dose per carton… Out of specification for dissolution. |
| Sep 2, 2025 | Class II | D-0007-2026 | Norgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and… Failed Content Uniformity Specifications |
| Aug 25, 2025 | Class II | D-0643-2025 | chloroproMAZINE Hydrochloride Tablets, USP, 50 mg, 50 Tablets (5x10) unit dose carton, Rx… and 1 more product Presence of a foreign substance. |
| Jun 26, 2025 | Class III | D-0528-2025 | Pitavastatin Tablets, 1 mg, 90 Tablets per bottle, Rx Only, Manufactured for: AvKARE… and 1 more product Failed Impurity/Degradation Specifications |
| May 13, 2025 | Class II | D-0460-2025 | Celecoxib Capsules, 200 mg, 50 Capsules (5x10) Unit Dose per carton, Rx Only, Manufactured… Presence of Foreign Tablets/Capsules: manufacturer recalled because one tadalafil 5mg tablet was found in 500 count bottle of Celecoxib 200… |
| May 9, 2025 | Class II | D-0461-2025 | Chlorthalidone Tablets, USP, 25 mg, 50 Tablets (5x10) Unit Dose cards per carton, Rx only… Failed Dissolution Specifications |
| Feb 4, 2025 | Class II | D-0229-2025 | Silodosin Capsules, 8mg, 90-count bottle, Rx only, Manufactured for: AvKare, Pulaski, TN… Subpotent Drug: Out of Specification (OOS) result for De hydro Impurity (0.654%) for 18 M Stability sample and low assay 94.9%… |
| Jan 21, 2025 | Class II | D-0224-2025 | Irbesartan Tablets USP, 300 mg, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured… Out of Specification for Dissolution |
FDA record score
82 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
31 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Class I recall D-0444-2024, this FEI as the recalling firm | Mar 28, 2024 | 15 x 0.6 | 9 |
| Class II recall D-0157-2027, this FEI as the recalling firm | Oct 9, 2026 | 4 x 1 | 4 |
| Class II recall D-0341-2026, this FEI as the recalling firm | Feb 13, 2026 | 4 x 1 | 4 |
| Class II recall D-0292-2026, this FEI as the recalling firm | Dec 31, 2025 | 4 x 1 | 4 |
| Class II recall D-0007-2026, this FEI as the recalling firm | Sep 2, 2025 | 4 x 1 | 4 |
| Class II recall D-0643-2025, this FEI as the recalling firm | Aug 25, 2025 | 4 x 1 | 4 |
| Class II recall D-0460-2025, this FEI as the recalling firm | May 13, 2025 | 4 x 1 | 4 |
| Class II recall D-0461-2025, this FEI as the recalling firm | May 9, 2025 | 4 x 1 | 4 |
| Class II recall D-0229-2025, this FEI as the recalling firm | Feb 4, 2025 | 4 x 1 | 4 |
| Class II recall D-0224-2025, this FEI as the recalling firm | Jan 21, 2025 | 4 x 1 | 4 |
| Class II recall D-0168-2025, this FEI as the recalling firm | Dec 4, 2024 | 4 x 1 | 4 |
| Class II recall D-0108-2025, this FEI as the recalling firm | Nov 27, 2024 | 4 x 1 | 4 |
| Class I recall D-0167-2021, this FEI as the recalling firm | Dec 7, 2020 | 15 x 0.25 | 3.8 |
| Inspection classified VAI | Nov 2, 2022 | 6 x 0.6 | 3.6 |
| Class II recall D-0103-2025, this FEI as the recalling firm | Oct 18, 2024 | 4 x 0.6 | 2.4 |
| Class II recall D-1146-2023, this FEI as the recalling firm | Aug 11, 2023 | 4 x 0.6 | 2.4 |
| Class II recall D-0091-2023, this FEI as the recalling firm | Dec 22, 2022 | 4 x 0.6 | 2.4 |
| Class II recall D-0070-2021, this FEI as the recalling firm | Oct 30, 2020 | 4 x 0.25 | 1 |
| Class II recall D-1304-2020, this FEI as the recalling firm | Jun 4, 2020 | 4 x 0.25 | 1 |
| Class II recall D-0661-2020, this FEI as the recalling firm | Jan 7, 2020 | 4 x 0.25 | 1 |
| Class II recall D-0524-2020, this FEI as the recalling firm | Nov 14, 2019 | 4 x 0.25 | 1 |
| Class II recall D-0164-2020, this FEI as the recalling firm | Oct 17, 2019 | 4 x 0.25 | 1 |
| Class II recall D-1875-2019, this FEI as the recalling firm | Aug 28, 2019 | 4 x 0.25 | 1 |
| Class II recall D-1249-2019, this FEI as the recalling firm | Apr 24, 2019 | 4 x 0.25 | 1 |
| Class II recall D-1044-2019, this FEI as the recalling firm | Mar 5, 2019 | 4 x 0.25 | 1 |
| Class II recall D-0285-2019, this FEI as the recalling firm | Nov 20, 2018 | 4 x 0.25 | 1 |
| Class II recall D-1130-2018, this FEI as the recalling firm | Aug 14, 2018 | 4 x 0.25 | 1 |
| Class II recall D-0633-2018, this FEI as the recalling firm | Mar 30, 2018 | 4 x 0.25 | 1 |
| Class II recall D-0222-2018, this FEI as the recalling firm | Jan 3, 2018 | 4 x 0.25 | 1 |
| Class II recall D-0055-2018, this FEI as the recalling firm | Oct 6, 2017 | 4 x 0.25 | 1 |
| Class II recall D-0610-2017, this FEI as the recalling firm | Feb 15, 2017 | 4 x 0.25 | 1 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing AvKARE as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check AvKARE yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- AvKARE
- Location
- Pulaski, TN (US)
- Source
- inspections